ERN-EuroBloodNet Advances Work on Sickle Cell Disease

In recent months, the ERN-EuroBloodNet has been involved in work related to sickle cell disease (SCD). On 19 June, the Educational and Patients Program Manager of the ERN-EuroBloodNet, Mariangela Pellegrini, participated in the inaugural International Conference on Sickle Cell Disease in Lusophone Countries. The event focused on the Lancet Haematology Commission’s 12 recommendations on SCD.

Also in June, the ERN-EuroBloodNet released a new publication, “Limited access to transcranial doppler screening and stroke prevention for children with sickle cell disease in Europe: Results of a multinational EuroBloodNet survey”. In addition, the ERN-EuroBloodNet’s second training programme on AI for haematology, offered with GenoMed4All and conceived by the latter’s Educational Scientific/Technical Committee, started on 18 September, with a focus on three rare blood conditions: sickle cell disease, myelodysplastic syndromes, and multiple myeloma.

Stay up to date

    © CSL 2026

    Blood & Beyond is a multi-stakeholder initiative funded by CSL, involving experts from the fields of haematology, transfusion medicine, anaesthesiology, patient blood management, nursing, patient advocacy, health economics, and hospital management, with support from policymakers committed to driving improvements in this area. The aim of the initiative is to raise awareness of the importance of good blood health and of the impact of anaemia on patients, healthcare systems and society at large, with the overarching goal to help advance policies and practices that improve patient outcomes by supporting patient-centricity in anaemia prevention, diagnosis, and management through patient blood management (PBM) and innovation.

    Contact

    For further information and queries, please contact the Blood and Beyond Secretariat: javier.lopezpanos@dgagroup.com

    Privacy Preference Center